Bristol-Myers shares up after top investor resists Celgene deal - Business Insights

Breaking

Post Top Ad

Post Top Ad

Thursday, February 28, 2019

Bristol-Myers shares up after top investor resists Celgene deal

Bristol-Myers Squibb Co expressed disappointment on Thursday with the opposition of its top shareholder to a $74 billion takeover of Celgene Corp, and said it would press on with what would be the largest pharmaceutical acquisition of all time.
Read more at: Source

No comments:

Post a Comment

Post Top Ad